Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1996-1-11
pubmed:databankReference
pubmed:abstractText
Novel retroviral protein expression constructs were designed to retain minimal retroviral sequences and to express dominant selectable markers by reinitiation of translation after expression of the viral genes. HT1080 cells were selected as producer cells for their ability to release high-titer viruses that are resistant to inactivation by human serum. Two HT1080-based packaging cell lines which produce Moloney murine leukemia virus cores with envelope glycoproteins of either amphotropic murine leukemia virus (FLYA13 line) or cat endogenous virus RD114 (FLYRD18 line) are described. Direct comparison with previous retroviral packaging systems indicated that 100-fold-higher titers of helper-free recombinant viruses were released by the FLYA13 and FLYRD18 lines.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-1310758, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-1608446, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-1691887, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-1700865, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-1720391, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-1762923, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-1850008, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-1851887, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-1989392, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-2072445, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-2081186, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-2152828, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-2153240, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-2154593, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-2173788, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-2330675, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-2352330, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-2450783, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-2462064, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-2462307, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-2840658, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-3413107, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-3683388, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-4357865, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-6090693, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-6169994, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-7511170, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-7778301, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-7871738, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-7966590, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-7966619, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-8041748, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-8046749, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-8207799, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-8382402, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-8385311, http://linkedlifedata.com/resource/pubmed/commentcorrection/7494248-8411376
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7430-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:7494248-Animals, pubmed-meshheading:7494248-Base Sequence, pubmed-meshheading:7494248-Blood, pubmed-meshheading:7494248-Cats, pubmed-meshheading:7494248-Cell Line, pubmed-meshheading:7494248-DNA Primers, pubmed-meshheading:7494248-Genes, env, pubmed-meshheading:7494248-Genes, pol, pubmed-meshheading:7494248-HeLa Cells, pubmed-meshheading:7494248-Humans, pubmed-meshheading:7494248-Leukemia Virus, Murine, pubmed-meshheading:7494248-Mice, pubmed-meshheading:7494248-Molecular Sequence Data, pubmed-meshheading:7494248-Moloney murine leukemia virus, pubmed-meshheading:7494248-Polymerase Chain Reaction, pubmed-meshheading:7494248-Recombination, Genetic, pubmed-meshheading:7494248-Retroviridae, pubmed-meshheading:7494248-Viral Envelope Proteins, pubmed-meshheading:7494248-Virus Replication
pubmed:year
1995
pubmed:articleTitle
High-titer packaging cells producing recombinant retroviruses resistant to human serum.
pubmed:affiliation
Chester Beatty Laboratory, Institute of Cancer Research, London, United Kingdom.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't